Audit Director, Quality & Compliance jobs in United States
cer-icon
Apply on Employer Site
company-logo

Cabaletta Bio · 1 day ago

Audit Director, Quality & Compliance

Cabaletta Bio is a clinical-stage biotechnology company focused on developing curative targeted cell therapies for autoimmune diseases. The Audit Director will lead the GxP audit program, ensuring compliance with global regulatory expectations and managing the audit team to maintain inspection readiness.

BiotechnologyHealth CareMedicalRoboticsTherapeutics

Responsibilities

Develop and maintain the annual risk-based Internal Audit Program across GCP, GMP, GLP, IT/CSV, and Quality Management System (QMS) domains
Plan, schedule, and execute internal audits, vendor audits, and for-cause audits
Ensure alignment with global regulatory requirements and industry best practices for advanced therapies and cell therapy manufacturing
Evaluate organizational risk and adjust audit scope and approach accordingly
Directly supervise the current audit team member including goal setting, workload planning, performance management, and professional development
Provide coaching, technical training, and oversight to ensure audit readiness and consistent application of audit standards
Support team succession planning and capability building as the audit function grows
Lead or oversee audits of internal functional areas (e.g., Clinical Operations, CMC, MSAT, Manufacturing, Quality Control, Regulatory Affairs, IT)
Oversee vendor and third-party audits to qualify and maintain GxP suppliers
Ensure timely issuance of audit reports, management responses, and CAPA plans
Track, trend, and monitor CAPA effectiveness and timely closure
Partner with CMR, CMC, and Quality teams to drive enterprise-wide inspection readiness for FDA, EMA, and other regulatory agencies
Identify systemic issues and organizational risks through audits and propose proactive mitigation strategies
Serve as a subject matter expert during inspections, helping teams respond to regulatory requests and remediation activities
Maintain and enhance audit-related SOPs, templates, and quality processes
Provide regular updates to Chief Compliance Office and operational leadership team, governance committees as required
Lead quality risk assessments and feed critical risks into the enterprise risk management framework
Contribute to QMS improvements to support operational excellence and commercial readiness
Partner with CMR, CMC, Manufacturing, Translational Sciences, IT, Regulatory, and Legal to ensure alignment on compliance expectations
Serve as a trusted advisor on GxP compliance and risk
Support training initiatives and lessons learned from audits

Qualification

GxP audit experienceFDA regulations knowledgeLeadership experienceQuality Management SystemRegulatory inspections supportCertifications ASQCertifications RACAnalytical skillsOrganizational skillsCommunication skillsCollaboration skillsAdaptability

Required

Bachelor's degree in Life Sciences, Quality, Regulatory, or related discipline
10+ years of GxP audit experience in biotechnology, pharmaceutical, or cell therapy environment
Demonstrated experience leading internal and external GxP audits
Strong understanding of FDA, EMA, MHRA, and ICH regulations (including ICH E6 R3, Annex 1, 21 CFR Parts 210/211/312/820, GCP/GMP/GLP)
Experience supervising or mentoring employees
Strong analytical, organizational, and communication skills
Ability to manage competing priorities in a fast-paced, rapidly growing company

Preferred

Experience in advanced therapies, ATMPs, or cell/gene therapy manufacturing
Experience preparing for and supporting regulatory inspections
Certifications such as ASQ, RQAP-GCP/GMP, RAC, CQA, or equivalent
Experience with QMS systems

Benefits

Competitive benefits
PTO
Stock option plans

Company

Cabaletta Bio

twittertwittertwitter
company-logo
Cabaletta Bio has adapted clinically-validated and FDA-approved CAR T cell technology to target B cell-mediated autoimmune diseases.

Funding

Current Stage
Public Company
Total Funding
$310M
Key Investors
5AM Ventures
2025-06-11Post Ipo Equity· $100M
2023-05-17Post Ipo Equity· $87M
2022-12-08Post Ipo Equity· $35M

Leadership Team

leader-logo
Samik Basu
Chief Scientific Officer
linkedin
leader-logo
Steve Gavel
Chief Commercial Officer
linkedin
Company data provided by crunchbase